fenretinide repurposed (ISLA-101) / Island Pharma - LARVOL DELTA

PROTECT: Study to Examine the Effects of Oral Fenretinide (clinicaltrials.gov) - P2 | N=15 | Completed | Sponsor: Island Pharmaceuticals | Active, not recruiting ➔ Completed

Trial completion • Dengue Fever

PROTECT: Study to Examine the Effects of Oral Fenretinide (clinicaltrials.gov) - P2 | N=15 | Active, not recruiting | Sponsor: Island Pharmaceuticals | Recruiting ➔ Active, not recruiting

Enrollment closed • Dengue Fever

PROTECT: Study to Examine the Effects of Oral Fenretinide (clinicaltrials.gov) - P2 | N=14 | Recruiting | Sponsor: Island Pharmaceuticals | Not yet recruiting ➔ Recruiting

Enrollment open • Dengue Fever

PROTECT: Study to Examine the Effects of Oral Fenretinide (clinicaltrials.gov) - P2 | N=14 | Not yet recruiting | Sponsor: Island Pharmaceuticals

New P2 trial • Dengue Fever